SF3A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.156200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.157200E-01
Normal-vs-Stage2
2.137800E-01
Normal-vs-Stage3
9.280100E-02
Normal-vs-Stage4
9.257800E-01
Stage1-vs-Stage2
5.587400E-01
Stage1-vs-Stage3
1.624080E-02
Stage1-vs-Stage4
4.533600E-02
Stage2-vs-Stage3
9.316400E-02
Stage2-vs-Stage4
1.881600E-01
Stage3-vs-Stage4
6.696800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.922990E-01
Normal-vs-AfricanAmerican
9.516200E-01
Normal-vs-Asian
1.752150E-01
Caucasian-vs-AfricanAmerican
8.896300E-02
Caucasian-vs-Asian
3.246400E-01
AfricanAmerican-vs-Asian
8.591700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.179800E-01
Normal-vs-Female
2.244800E-01
Male-vs-Female
9.154400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.058000E-01
Normal-vs-Age(41-60Yrs)
4.150400E-01
Normal-vs-Age(61-80Yrs)
1.896220E-01
Normal-vs-Age(81-100Yrs)
2.886200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.068200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.263600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.405200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.779890E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.391800E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.700400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.607900E-02
Normal-vs-Daily Drinker
1.160830E-01
Normal-vs-Weekly Drinker
2.320600E-01
Normal-vs-Occasional Drinker
4.372800E-01
Normal-vs-Social Drinker
2.955000E-01
Non Drinker-vs-Daily Drinker
9.485000E-01
Non Drinker-vs-Weekly Drinker
5.785600E-01
Non Drinker-vs-Occasional Drinker
5.941700E-02
Non Drinker-vs-Social Drinker
2.340400E-01
Daily Drinker-vs-Weekly Drinker
5.750800E-01
Daily Drinker-vs-Occasional Drinker
7.446400E-02
Daily Drinker-vs-Social Drinker
2.506000E-01
Weekly Drinker-vs-Occasional Drinker
2.930200E-01
Weekly Drinker-vs-Social Drinker
6.146000E-01
Occasional Drinker-vs-Social Drinker
5.663000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.810400E-01
Normal-vs-Grade 2
8.557000E-01
Normal-vs-Grade 3
8.735000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.248200E-01
Grade 1-vs-Grade 3
9.241400E-01
Grade 1-vs-Grade 4
8.810400E-01
Grade 2-vs-Grade 3
6.841600E-01
Grade 2-vs-Grade 4
8.557000E-01
Grade 3-vs-Grade 4
8.735000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.519020E-01
Normal-vs-NonDiabetic
1.784210E-01
Diabetic-vs-NonDiabetic
6.779000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.654980E-01
Normal-vs-NoPancreatitis
1.991020E-01
Pancreatitis-vs-NoPancreatitis
6.912800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.474200E-01
Normal-vs-N1
2.308000E-01
N0-vs-N1
8.743600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.460200E-01
Normal-vs-TP53-NonMutant
4.675600E-01
TP53-Mutant-vs-TP53-NonMutant
3.521200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
